| Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials C Axfors, AM Schmitt, P Janiaud, J van 't Hooft, S Abd-Elsalam, EF Abdo, ... Nature Communications 12 (2349), https://doi.org/10.1038/s41467-021-22446, 2021 | 352 | 2021 |
| COVID-19-associated brief psychotic disorder CM Smith, JR Komisar, A Mourad, BR Kincaid BMJ Case Reports 13 (8), e236940, 2020 | 133 | 2020 |
| Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised … WH Self, U Sandkovsky, CS Reilly, DM Vock, RL Gottlieb, M Mack, ... The Lancet Infectious Diseases 22 (5), 622-635, 2022 | 125 | 2022 |
| The War on Cryptococcosis: A Review of the Antifungal Arsenal A Mourad, JR Perfect Mem Inst Oswaldo Cruz, Rio de Janeiro 1 (7), 1, 2018 | 80 | 2018 |
| Present and Future Therapy of Cryptococcus Infections A Mourad, JR Perfect Journal of Fungi 4 (3), 79, 2018 | 61 | 2018 |
| Tixagevimab/Cilgavimab for Treatment of Hospitalised COVID-19 Patients: A Randomised, Double-Blind, Phase 3 Trial TL Holland, AA Ginde, R Paredes, TA Murray, N Engen, G Grandits, ... Lancet Respiratory Medicine, doi: 10.1016/S2213-2600(22)00215-6, 2022 | 60* | 2022 |
| Tolerability Profile of the Current Antifungal Armoury A Mourad, JR Perfect Journal of Antimicrobial Chemotherapy 73 (suppl_1), i26-i32, 2018 | 55 | 2018 |
| The What or the How: A Review of Teaching Tools and Methods in Medical Education A Mourad, A Jurjus, IH Hussein Medical Science Educator 26 (4), 723-728, 2016 | 44 | 2016 |
| The association of baseline plasma SARS-CoV-2 nucleocapsid antigen level and outcomes in patients hospitalized with COVID-19 ACTIV-3/TICO Study Group Annals of internal medicine 175 (10), 1401-1410, 2022 | 33 | 2022 |
| Reduction in Expected Survival Associated with Nontuberculous Mycobacterial Pulmonary Disease A Mourad, AW Baker, JE Stout Clinical Infectious Diseases, 2020 | 24 | 2020 |
| The Homozygous CX3CR1-M280 Mutation Impairs Human Monocyte Survival AL Collar, M Swamydas, MSS Morgan O’Hayre, KW Hoffman, SP Singh, ... JCI insight 3 (3), 2018 | 24 | 2018 |
| Social Disadvantage, Politics, and SARS-CoV-2 Trends: A County-Level Analysis of United States Data A Mourad, NA Turner, AW Baker, NL Okeke, S Narayanasamy, R Rolfe, ... Clinical Infectious Diseases 72 (10), e604–e607, 2021 | 21* | 2021 |
| Real-world implications of QT prolongation in patients receiving voriconazole and amiodarone A Mourad, JA Stiber, JR Perfect, MD Johnson Journal of Antimicrobial Chemotherapy, 2018 | 16 | 2018 |
| Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial TG Stewart, PA Rebolledo, A Mourad, CJ Lindsell, DR Boulware, ... JAMA, 2023 | 11* | 2023 |
| Dexamethasone for Inpatients With COVID-19 in a National Cohort A Mourad, D Thibault, TL Holland, S Tang, AR Young, SA Arnold Egloff, ... JAMA Network Open 6 (4), e238516, 2023 | 9 | 2023 |
| What can the clinical mycology laboratory do for clinicians today and tomorrow? A Mourad, JR Perfect Current Clinical Microbiology Reports 4, 96-105, 2017 | 6 | 2017 |
| The Remote Misses of COVID-19 A Mourad Annals of Internal Medicine, 2020 | 5 | 2020 |
| QTc prolongation in patients receiving triazoles and amiodarone K Cook, T Sraubol, KB Campbell, A Mourad, J Stiber, JR Perfect, ... Open Forum Infectious Diseases 4 (suppl_1), S84-S84, 2017 | 5 | 2017 |
| Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial SM Brown, CE Barkauskas, B Grund, S Sharma, AN Phillips, L Leither, ... The Lancet Respiratory Medicine 11 (9), 791-803, 2023 | 4 | 2023 |
| Surgical infection prophylaxis prior to left ventricular assist device implantation: A survey of clinical practice A Mourad, S Arif, M Bishawi, C Milano, RA Miller, SA Maskarinec Journal of Cardiac Surgey 35 (10), 2672-2678, 2020 | 4 | 2020 |
